Jason M. Meggs - Jun 30, 2021 Form 4 Insider Report for Syneos Health, Inc. (SYNH)

Role
Chief Financial Officer
Signature
/s/ Sara Epstein, Attorney-in-Fact
Stock symbol
SYNH
Transactions as of
Jun 30, 2021
Transactions value $
-$219,377
Form type
4
Date filed
7/2/2021, 05:04 PM
Next filing
Jul 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Options Exercise $89.3K +2.07K +3.41% $43.16 62.8K Jun 30, 2021 Direct F1
transaction SYNH Class A Common Stock Sale -$186K -2.07K -3.29% $90.00 60.7K Jun 30, 2021 Direct F1
transaction SYNH Class A Common Stock Options Exercise $111K +2.6K +4.28% $42.88 63.3K Jun 30, 2021 Direct F1
transaction SYNH Class A Common Stock Sale -$234K -2.6K -4.11% $90.00 60.7K Jun 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYNH Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -2.6K -100% $0.00* 0 Jun 30, 2021 Class A Common Stock 2.6K $42.88 Direct F2
transaction SYNH Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -2.07K -98.1% $0.00 40 Jun 30, 2021 Class A Common Stock 2.07K $43.16 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
F2 The shares subject to this option vested in four approximately equal annual installments on January 19, 2017; January 19, 2018; January 19, 2019; and January 19, 2020.
F3 The shares subject to this option vested in four approximately equal annual installments on July 29, 2016; July 29, 2017; July 29, 2018; and July 29, 2019.